- Home
- RNXT vs PIII Comparison
RNXT vs PIII Comparison
Compare RNXT & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- PIII
- Stock Information
- Founded
- RNXT 2012
- PIII 2015
- Country
- RNXT United States
- PIII United States
- Employees
- RNXT N/A
- PIII N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- PIII Medical/Nursing Services
- Sector
- RNXT Health Care
- PIII Health Care
- Exchange
- RNXT Nasdaq
- PIII Nasdaq
- Market Cap
- RNXT 37.6M
- PIII 30.8M
- IPO Year
- RNXT 2021
- PIII N/A
- Fundamental
- Price
- RNXT $1.06
- PIII $8.45
- Analyst Decision
- RNXT Strong Buy
- PIII Buy
- Analyst Count
- RNXT 2
- PIII 2
- Target Price
- RNXT $7.00
- PIII $16.25
- AVG Volume (30 Days)
- RNXT 117.4K
- PIII 17.3K
- Earning Date
- RNXT 05-15-2025
- PIII 05-15-2025
- Dividend Yield
- RNXT N/A
- PIII N/A
- EPS Growth
- RNXT N/A
- PIII N/A
- EPS
- RNXT N/A
- PIII N/A
- Revenue
- RNXT $43,000.00
- PIII $1,500,455,000.00
- Revenue This Year
- RNXT $4,755.81
- PIII N/A
- Revenue Next Year
- RNXT $187.93
- PIII $6.41
- P/E Ratio
- RNXT N/A
- PIII N/A
- Revenue Growth
- RNXT N/A
- PIII 18.48
- 52 Week Low
- RNXT $0.75
- PIII $7.00
- 52 Week High
- RNXT $1.69
- PIII $39.50
- Technical
- Relative Strength Index (RSI)
- RNXT 60.35
- PIII 44.15
- Support Level
- RNXT $1.02
- PIII $8.17
- Resistance Level
- RNXT $1.09
- PIII $8.71
- Average True Range (ATR)
- RNXT 0.05
- PIII 0.53
- MACD
- RNXT 0.01
- PIII -0.04
- Stochastic Oscillator
- RNXT 80.00
- PIII 18.07
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.